CYP3A4
Cytochrome P450 3A4
Also known as: CP3A4_HUMAN, CYP3A3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08684
- Gene
- CYP3A4
- Ensembl
- ENSG00000160868
- Chromosome
- 7
- Canonical length
- 503 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Vesicles,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020]
Canonical amino-acid sequenceUniProt
503 residues, UniProt reviewed canonical sequence.
>P08684|CYP3A4
1 MALIPDLAME TWLLLAVSLV LLYLYGTHSH GLFKKLGIPG PTPLPFLGNI LSYHKGFCMF
61 DMECHKKYGK VWGFYDGQQP VLAITDPDMI KTVLVKECYS VFTNRRPFGP VGFMKSAISI
121 AEDEEWKRLR SLLSPTFTSG KLKEMVPIIA QYGDVLVRNL RREAETGKPV TLKDVFGAYS
181 MDVITSTSFG VNIDSLNNPQ DPFVENTKKL LRFDFLDPFF LSITVFPFLI PILEVLNICV
241 FPREVTNFLR KSVKRMKESR LEDTQKHRVD FLQLMIDSQN SKETESHKAL SDLELVAQSI
301 IFIFAGYETT SSVLSFIMYE LATHPDVQQK LQEEIDAVLP NKAPPTYDTV LQMEYLDMVV
361 NETLRLFPIA MRLERVCKKD VEINGMFIPK GVVVMIPSYA LHRDPKYWTE PEKFLPERFS
421 KKNKDNIDPY IYTPFGSGPR NCIGMRFALM NMKLALIRVL QNFSFKPCKE TQIPLKLSLG
481 GLLQPEKPVV LKVESRDGTV SGALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP3A4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 3,367 nTPM
Expression across tissuesHPA
Tissue
- liver: 3,367 nTPM
- small intestine: 755 nTPM
- duodenum: 713 nTPM
- pancreas: 25 nTPM
- kidney: 4.2 nTPM
- adrenal gland: 3.4 nTPM
Single-cell type
- hepatocytes: 3,989 nCPM
- enterocytes: 2,040 nCPM
- paneth cells: 46 nCPM
- hepatic stellate cells: 32 nCPM
- cholangiocytes: 29 nCPM
- cardiomyocytes: 18 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 3.3 nTPM
- white matter: 2.8 nTPM
- cerebellum: 2.2 nTPM
- thalamus: 2.2 nTPM
- basal ganglia: 2.1 nTPM
- amygdala: 1.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CYP3A4.
Disease | AllUniProt
Conditions CYP3A4 is implicated in, by any mechanism.
- Vitamin D-dependent rickets 3 (VDDR3) MIM:619073
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 39 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Vitamin D-dependent rickets, type 3
- Familial hypercholesterolemia
ReferencesPubMed · IEDB
Publications for CYP3A4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure.
2014 · Hepatology · RCR 3.5 · 92 citations - Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics.
1999 · Mol Pharmacol · RCR 1.5 · 51 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.35
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aflatoxin metabolic process
- alkaloid catabolic process
- androgen metabolic process
- cholesterol metabolic process
- estrogen metabolic process
- lipid hydroxylation
- lipid metabolic process
- long-chain fatty acid biosynthetic process
- monoterpenoid metabolic process
- oxidative demethylation
- retinoic acid metabolic process
- retinol metabolic process
- steroid catabolic process
- steroid metabolic process
- vitamin D catabolic process
- vitamin D metabolic process
- xenobiotic catabolic process
- xenobiotic metabolic process
Molecular functions
- 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity
- anandamide 11,12 epoxidase activity
- anandamide 14,15 epoxidase activity
- anandamide 8,9 epoxidase activity
- caffeine oxidase activity
- enzyme binding
- estrogen 16-alpha-hydroxylase activity
- estrogen 2-hydroxylase activity
- heme binding
- iron ion binding
- monooxygenase activity
- oxidoreductase activity
- oxygen binding
- retinoic acid 4-hydroxylase activity
- steroid binding
- steroid hydroxylase activity
- testosterone 6-beta-hydroxylase activity
- vitamin D 24-hydroxylase activity
- vitamin D3 25-hydroxylase activity
- 1,8-cineole 2-exo-monooxygenase activity
- quinine 3-monooxygenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CYP3A4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP3A4 as an antibody target. Whether an autoantibody or antibody against CYP3A4 could matter depends on whether native CYP3A4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP3A4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP3A4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...